ValuEngine Downgrades PHI (PHII) to Hold

PHI (NASDAQ:PHII) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Friday.

Shares of PHI (NASDAQ PHII) opened at $11.95 on Friday. PHI has a 52-week low of $9.01 and a 52-week high of $16.77. The company has a debt-to-equity ratio of 1.03, a quick ratio of 5.96 and a current ratio of 7.19.

PHI (NASDAQ:PHII) last announced its earnings results on Friday, November 3rd. The energy producer reported ($0.21) earnings per share (EPS) for the quarter. PHI had a negative return on equity of 6.61% and a negative net margin of 6.75%. The business had revenue of $150.17 million for the quarter.

An institutional investor recently bought a new position in PHI stock. Malaga Cove Capital LLC acquired a new stake in PHI Inc. (NASDAQ:PHII) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 31,492 shares of the energy producer’s stock, valued at approximately $374,000. Malaga Cove Capital LLC owned about 0.20% of PHI as of its most recent SEC filing. 1.86% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at

PHI Company Profile

PHI, Inc is engaged in transportation of personnel to, from, and among offshore platforms for customers engaged in the oil and gas exploration, development and production industry. The Company offers these services in various domestic and international markets. Most of its offshore flight operations are concentrated in the Gulf of Mexico.

Receive News & Ratings for PHI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PHI and related companies with's FREE daily email newsletter.

Leave a Reply